🔎 Trials Near Me

Nyumbani › Alopecia Areata

Majaribio ya kliniki ya Alopecia Areata yanayovutia washiriki nchini Marekani

Masomo 17 ya Alopecia Areata yanavutia washiriki katika vituo vya Marekani nzima.

Miji yenye masomo mengi

Kwa jimbo

Masomo yaliyosasishwa hivi karibuni

Maandishi rasmi ya utafiti (Kiingereza)

A Study to Evaluate the Safety and Effectiveness of Upadacitinib in Pediatric Participants With Alopecia Areata

InaajiriHatua 3
Umri 6 hadi 17 · Jinsia zote · Imesasishwa 2 Okt 2026 · NCT07772492

A Study of LY4005130 in Adult Participants With Severe Alopecia Areata (Hair Loss)

InaajiriHatua 2
Umri 18 hadi 50 · Jinsia zote · Imesasishwa 22 Sep 2026 · NCT07533006

A Study of 2 Doses of Ritlecitinib in People 12 Years of Age and Older With Alopecia Areata

InaajiriHatua 3
Umri 12 na zaidi · Jinsia zote · Imesasishwa 18 Sep 2026 · NCT06873945

HCW9302 (Interleukin-2 Fusion Protein) for Alopecia Areata

InaajiriHatua 1
Umri 18 hadi 70 · Jinsia zote · Imesasishwa 15 Sep 2026 · NCT07049328

Dupilumab in the Treatment of Pediatric Alopecia Areata

InaajiriHatua 2
Umri 6 hadi 17 · Jinsia zote · Imesasishwa 2 Sep 2026 · NCT05866562

CorEvitas International Adolescent Alopecia Areata (AA) Drug Safety and Effectiveness Registry

InaajiriUtafiti wa uchunguzi
Umri 12 hadi 17 · Jinsia zote · Imesasishwa 17 Ago 2026 · NCT06562270

Evaluation of Microbiota Transplant Therapy in Patients With Alopecia Areata

InaajiriHatua 2
Umri 18 hadi 75 · Jinsia zote · Imesasishwa 26 Jun 2026 · NCT06747611

Evaluate the Efficacy and Safety of Ruxolitinib on Hair Regrowth in Patients With Autoimmune Polyendocrinopathy Candidiasis Ectodermal Dystrophy (APECED)-Associated Alopecia Areata

InaajiriHatua 2Wajitolea wenye afya wanakaribishwa
Umri 12 hadi 75 · Jinsia zote · Imesasishwa 22 Jun 2026 · NCT05398809

Regeneron AA Multicenter (Dupilumab)

InaajiriHatua 2
Umri 18 na zaidi · Jinsia zote · Imesasishwa 17 Jun 2026 · NCT05551793

A Study of LAD603 in Adults With Alopecia Areata

InaajiriHatua 2
Umri 18 hadi 65 · Jinsia zote · Imesasishwa 20 Mei 2026 · NCT07311564

A Long-Term Study to Learn About The Study Medicine Called Ritlecitinib in Children With Severe Alopecia Areata.

InaajiriHatua 3
Umri 6 hadi 14 · Jinsia zote · Imesasishwa 28 Apr 2026 · NCT07029828

CorEvitas Alopecia Areata (AA) Safety and Effectiveness Registry

InaajiriUtafiti wa uchunguzi
Umri 18 na zaidi · Jinsia zote · Imesasishwa 9 Feb 2026 · NCT05745389

Treatment of Atopic Dermatitis and Alopecia Areata With Abrocitinib in Individuals With Down Syndrome

InaajiriHatua 2
Umri 12 na zaidi · Jinsia zote · Imesasishwa 2 Feb 2026 · NCT07242638

Study to Evaluate the Efficacy and Safety of Deuruxolitinib in Adolescents With Severe Alopecia Areata

InaajiriHatua 3
Umri 12 hadi 17 · Jinsia zote · Imesasishwa 28 Jan 2026 · NCT07133308

Kutoka ClinicalTrials.gov, data iliyopatikana 5 Okt 2026. Kila utafiti una masharti yake ya kufaa; timu ya utafiti huamua nani anaweza kujiunga.